Synthesis of 5-radioiodoarabinosyl uridine analog for probing HSV-1 thymidine kinase gene: an unexpected chelating effect

Nuclear Medicine and Biology

Volumn 33, Issue 3, 2006, Pages 367-370

  Yu, Chung Shan ^a   Chiang, Li Wu ^a   Wu, Chien Hung ^a   Wang, Ren Tsong ^a   Chen, Shao Wei ^a   Wang, Heng Yen ^a   Yeh, Chien Hung ^a  

^a NATIONAL TSING HUA UNIVERSITY   (Taiwan)

Author keywords

Arabinosyl; Chelating; HSV 1 TK; PET; Tin; Uridine

Indexed keywords

5 IODOARABINOSYL URIDINE I 125; HYDROXYL GROUP; RADIOPHARMACEUTICAL AGENT; THYMIDINE KINASE; TIN DERIVATIVE; UNCLASSIFIED DRUG; URIDINE DERIVATIVE;

ARTICLE; CHEMICAL PROCEDURES; GENE PROBE; HERPES SIMPLEX VIRUS 1; MOLECULAR IMAGING; POSITRON EMISSION TOMOGRAPHY; PURIFICATION; SYNTHESIS; TUMOR CELL;

ARABINOFURANOSYLURACIL; CHELATING AGENTS; GENES, VIRAL; HUMANS; IODINE RADIOISOTOPES; SIMPLEXVIRUS; THYMIDINE KINASE;

EID: 33646070276     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nucmedbio.2005.12.005     Document Type: Article

References (34)

1. Peñuelas I., Boán J.F., Martý-Climent J.M., Sangro B., Mazzolini G., Prieto J., et al. Positron emission tomography and gene therapy: basic concepts and experimental approaches for in vivo gene expression imaging. Mol Imaging Biol 6 (2004) 225-238
2. Herschman H.R. PET reporter genes for noninvasive imaging of gene therapy, cell tracking and transgenic analysis. Crit Rev Oncol Hemat 51 (2004) 91-204
3. de Vries E.F.J., Buursma A.R., Hospers G.A.P., Mulder N.H., and Vaalburg W. Scintigraphic imaging of HSVtk gene therapy. Curr Pharm Des 8 (2002) 1435-1450
4. Nichol C., and Kim E.E. Molecular imaging and gene therapy. J Nucl Med 42 (2001) 1368-1374
5. Verel I., Visser G.W.M., Vosjan M.J.W.D., Finn R., Boellaard R., and van Dongen G.A.M.S. High quality I-124-labelled monoclonal antibodies for use as PET scouting agents prior to I-131-radioimmunotherapy. Eur J Nucl Med Mol Imaging 31 (2004) 1645-1652
6. Green L.A., Nguyen K., Berenji B., Iyer M., Bauer E., Barrio J.R., et al. A tracer kinetic model for F-18-FHBG for quantitating herpes simplex virus type 1 thymidine kinase reporter gene expression in living animals using PET. J Nucl Med 45 (2004) 1560-1570
7. Tjuvajev J.G., Avril N., Oku T., Sasajima T., Miyagawa T., Joshi R., et al. Imaging herpes virus thymidine kinase gene transfer and expression by positron emission tomography. Cancer Res 58 (1998) 4333-4341
8. Alauddin M.M., and Conti P.S. Synthesis and preliminary evaluation of 9-(4-[F-18]-fluoro-3-hydroxymethylbutyl)guanine ([F-18]FHBG): a new potential imaging agent for viral infection and gene therapy using PET. Nucl Med Biol 25 (1998) 175-180
9. Monclus M., Luxen A., Cool V., Damhaut P., Velu T., and Goldman S. Development of a positron emission tomography radiopharmaceutical for imaging thymidine kinase gene expression: synthesis and in vitro evaluation of 9-{(3-[F-18]fluoro-1-hydroxy-2-propoxy)methyl}guanine. Bioorg Med Chem Lett 7 (1997) 1879-1882
10. Alauddin M.M., Conti P.S., Mazza S.M., Hamzeh F.M., and Lever J.R. Synthesis of 9-[(3-[F-18]-fluoro-1-hydroxy-2-propoxy)methyl]guanine ([F-18]-FHPG): a potential imaging agent of viral infection and gene therapy using PET. Nucl Med Biol 23 (1996) 787-792
11. Min J.-J., Iyer M., and Gambhir S.S. Comparison of [F-18]FHBG and [C-14]FIAU for imaging of HSV1-tk reporter gene expression: adenoviral infection vs stable transfection. Eur J Nucl Med Mol Imaging 30 (2003) 1547-1560
12. Degrève B., Esnouf R., De Clercq E., and Balzarini J. Selective abolishment of pyrimidine nucleoside kinase activity of herpes simplex virus type 1 thymidine kinase by mutation of alanine-167 to tyrosine. Mol Pharmacol 58 (2000) 1326-1332
13. Balzarini J., Bohman C., Walker R.T., and De Clercq E. Comparative cytostatic activity of different antiherpetic drugs against herpes simplex virus thymidine kinase gene transfected tumor cells. Mol Pharmacol 45 (1994) 1253-1258
14. Balzarini J., Morin K.W., Knaus E.E., Wiebe L.I., and De Clercq E. Novel (E)-5-(2-iodovinyl)-2′-deoxyuridine derivatives as potential cytostatic agents against herpes simplex virus thymidine kinase gene transfected tumors. Gene Ther 2 (1995) 317-322
15. Yu C.-S., Wu C.-H., Chiang L.-W., Wang R.-T., Wang H.-Y., Yeh C.-H., et al. Synthesis of (E)-5-(2-radioiodovinyl)arabinosyl uridine analog for probing HSV-1 thymidine kinase gene. Chem Lett 34 (2005) 1390-1391
16. Yu C.-S., Eisenbarth J., Runz A., Weber K., Zeisler S., and Oberdorfer F. Syntheses of 5-(2-radiohaloethyl)- and 5-(2-radiohalovinyl)-2′-deoxyuridines. Novel types of radiotracer for monitoring cancer gene therapy with PET. J Label Compd Radiopharm 46 (2003) 421-439
17. Yu C.-S., and Oberdorfer F. Synthesis of a novel aldehyde: 4-O-methyl-5-formylmethyl-2′-deoxyuridine. Nucleosides Nucleotides Nucleic Acids 22 (2003) 71-84
18. Yu C.-S., and Oberdorfer F. Synthesis of 4-O-methyl-protected 5-(2-hydroxyethyl)-2′-deoxyuridine derivatives and their nucleophilic fluorination to 5-(2-fluoroethyl)-2′-deoxyuridine. Synthesis (1999) 2057-2064
19. Yu C.-S., and Oberdorfer F. Synthesis of (E)-5-[2-(tri-n-butylstannyl)vinyl] substituted 2′-deoxyuridine derivatives for use in halogenation and radiohalogenation reactions. Synlett (2000) 86-88
20. Vaidyanathan G., and Zalutsky M.R. Preparation of 5-[I-131]Iodo- and 5-[At-211]astato-1-(2-deoxy-2-fluoro-beta-d-arabinofuranosyl)uracil by a halodestannylation reaction. Nucl Med Biol 25 (1998) 487-496
21. Toyohara J., and Fujibayashi Y. Trends in nucleoside tracers for PET imaging of cell proliferation. Nucl Med Biol 30 (2003) 681-685
22. Ozaki H., Nakajima K., Tatsui K., Izumi C., Kuwahara M., and Sawai H. Convenient synthesis of oligodeoxyribonucleotides bearing arabinofuranosyl pyrimidine derivatives and its duplex formation with complementary DNA. Bioorg Med Chem Lett 13 (2003) 2441-2443
23. Wnuk S.F., Chowdhury S.M., Garcia J.P.I., and Robins M.J. Stereodefined synthesis of O3′-labeled uracil nucleosides. 3′-[O-17]-2′-azido-2′-deoxyuridine 5′-diphosphate as a probe for the mechanism of inactivation of ribonucleotide reductases. J Org Chem 67 (2002) 1816-1819
24. Schinazi R.F., Chen M.S., and Prusoff W.H. Anti-viral and anti-neoplastic activities of pyrimidine arabinosyl nucleosides and their 5′-amino derivatives. J Med Chem 22 (1979) 1273-1277
25. Hampton A., and Nichol A.W. Nucleotides. V. purine ribonucleoside 2′, 3′-cyclic carbonates. Preparation and use for the synthesis of 5′-monosubstituted nucleosides. Biochemistry 5 (1966) 2076
26. Pankiewicz K.W., and Watanabe K.A. Nucleosides. 143. Synthesis of 5′-deoxy-5′-substituted-2,2′-anhydro-1-(beta-d-arabinofuranosyl)uracils - a new 2,5′-anhydronucleoside to 2,2′-anhydronucleoside transformation - studies directed toward the synthesis of 2′-deoxy-2′-substituted arabino nucleosides.4. Chem Pharm Bull 35 (1987) 4494-4497
27. Codington J.F., Fecher R., and Fox J.J. Pyrimidine nucleosides. vii. reactions of 2′,3 ′,5′-trimesyloxyuridine. J Am Chem Soc 82 (1960) 2794-2803
28. Robin M.J., Manfredini S., Wood S.G., Wanklin R.J., Rennie B.A., and Sacks S.L. Nucleic acid related compounds. 65. New syntheses of 1-(beta-d-arabinofuranosyl)-5(E)-(2-iodovinyl)uracil (IVaraU) from vinylsilane precursors - radioiodine uptake as a marker for thymidine kinase positive herpes viral-infections. J Med Chem 34 (1991) 2275-2280
29. Lin T.-S., and Gao Y.S. Synthesis and biological-activity of 5-(trifluoromethyl)- and 5-(pentafluoroethyl)pyrimidine nucleoside analogs. J Med Chem 26 (1983) 598-601
30. Brown D.M., Todd A., and Varadarajan S. Nucleotides. XXXVII The structure of uridylic acids a and b, and a synthesis of spongouridine (3-β-d-arabofuranosyluracil). J Chem Soc (1966) 2388
31. Ono K., Ogasawara M., Ohashi A., Matsukage A., Takahashi T., Nakayama C., et al. Inhibitory effects of various 5-halogenated derivatives of 1-beta-d-arabinofuranosyluracil 5′-triphosphate on DNA polymerases from murine cells and oncornavirus substituent effects on inhibitory action. Biochemistry 21 (1982) 1019-1024
32. Saladino R., Crestini C., Francesca O., and Nicoletti R. Ozonation of thionucleosides - a new chemical transformation of 4-thiouracil and 6-thioguanine nucleosides to cytosine and adenosine counterparts. Tetrahedron 51 (1995) 3607-3616
33. Asakura J., and Robins M.J. Cerium(iv) catalyzed iodination at C5 of uracil nucleosides. Tetrahedron Lett 29 (1988) 2855-2858
34. Asakura J., and Robins M.J. Cerium(iv)-mediated halogenation at C-5 of uracil derivatives. J Org Chem 55 (1990) 4928-4933